Form D · Other Health Care

VentriPoint Diagnostics Ltd

Calgary, A0 · CIK 0001414336

Offering snapshot reported Jan 12, 2015 · SEC filing

Reported sold
$30.1K
Offering amount: $30.1K
Investors reported
2
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 31, 2014
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 12, 2015Initial$30,104No comparison2SEC filing
Aug 9, 2013Initial$20,000No comparison1SEC filing
May 24, 2013Initial$748,000No comparison1SEC filing
Apr 8, 2013Initial$50,217No comparison5SEC filing
May 15, 2012Initial$264,605No comparison5SEC filing
Jun 17, 2011Initial$1,159,798No comparison20SEC filing
Jan 4, 2011Initial$1,452,748No comparison47SEC filing
Oct 18, 2010Initial$97,714No comparison10SEC filing
Apr 1, 2010Initial$138,214No comparison4SEC filing
Oct 3, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Debt, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-231901
Each unit consists of $1,000 principal amount of non-convertible non-secured debentures which mature 1 year from 12/31/2014 and bears interest at a rate of 12% per annum and 16,667 cmn sh purch warrants for Cdn$0.06 thru 12/31/2016
Each unit consists of $1,000 principal amount of non-convertible non-secured debentures which mature 1 year from 12/31/2014 and bears interest at a rate of 12% per annum and 16,667 cmn sh purch warrants for Cdn$0.06 thru 12/31/2016

Source: Form D, filed Jan 12, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
George Adams Director, Executive
Scott Ashley Executive
Joseph Ashley Director, Executive
Don Black Director
Ellen Briant Executive
Hugh Cleland Director
Danny Dalla Longa Director
Edward Garth Executive
Jerry Gatewood Executive
John Gebhart Executive
Brad Harlow Director
Bradley Raines Harlow Director
Amol Karnick Executive
Treuman P Katz Director
Dr. Alan Rabinowitz Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
Suite 1000 Livingston Place West 250 2nd Street, Sw
Calgary, A0, T2P 0C1